🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Capsule(s) Serving Size
30 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Complex
800 mg

Other Ingredients

Hydroxypropyl Methylcellulose Cellulose powder Silica Vegetable Source Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Recommendations: 1 to 2 capsules daily, or as recommended by your healthcare practitioner.

⚠️ Warnings & Precautions

If pregnant or nursing, consult a healthcare practitioner before use.

🧪 Formulation Notes

ArthoMed is a proprietary formula that effectively supports joint health and cartilage formation. Supports healthy cartilage structure Optimizes comfort and mobility in articular joints and spine

In a scientific study, Devil’s Claw extract increased hyaluronic acid synthesis in chondrocytes by 41%; hyaluronic acid is critical for joint lubrication

Supports joint and spine health, flexibility and comfort

Clinically studied curcumin and boswellia

Vegan

Non-GMO

No sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or artificial preservatives.

Product Details

UPC / SKU 3 67703 70196 3
DSLD Entry Date 2022-05-19
Product Type Botanical
Form Capsule
Brand EuroMedica
DSLD ID 261524
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.